Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
Pursuing Board Changes to Restore Investor Confidence and Ensure Integrity of Ongoing Sale Process Broadwood Seeks to Remove the Directors Most Responsible for the Flawed Sale Process: Board Chair Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee
(Financial Post, 2025-12-02T21:24:52Z)